Preliminary Communication
Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
Daniel C. Link, MD; Laura G. Schuettpelz, MD, PhD; Dong Shen, MD, PhD; Jinling Wang, MD; Matthew J. Walter, MD; Shashikant Kulkarni, PhD; Jacqueline E. Payton, MD, PhD; Jennifer Ivanovich, MS; Paul J. Goodfellow, PhD; Michelle Le Beau, PhD; Daniel C. Koboldt, MS; David J. Dooling, PhD; Robert S. Fulton, MS; R. Hugh F. Bender, MS; Lucinda L. Fulton, MS; Kimberly D. Delehaunty, BA; Catrina C. Fronick, BS; Elizabeth L. Appelbaum, BA; Heather Schmidt, BS; Rachel Abbott, BS; Michelle O’Laughlin, BS; Ken Chen, PhD; Michael D. McLellan, BS; Nobish Varghese, MS; Rakesh Nagarajan, MD, PhD; Sharon Heath, CCRP; Timothy A. Graubert, MD; Li Ding, PhD; Timothy J. Ley, MD; Gerard P. Zambetti, PhD; Richard K. Wilson, PhD; Elaine R. Mardis, PhD
Preliminary Communication
Use of Whole-Genome Sequencing to Diagnose a Cryptic Fusion Oncogene
John S. Welch, MD, PhD; Peter Westervelt, MD, PhD; Li Ding, PhD; David E. Larson, PhD; Jeffery M. Klco, MD, PhD; Shashikant Kulkarni, PhD; John Wallis, PhD; Ken Chen, PhD; Jacqueline E. Payton, MD, PhD; Robert S. Fulton, MS; Joelle Veizer, BS; Heather Schmidt, BS; Tammi L. Vickery, BS; Sharon Heath; Mark A. Watson, MD, PhD; Michael H. Tomasson, MD; Daniel C. Link, MD; Timothy A. Graubert, MD; John F. DiPersio, MD, PhD; Elaine R. Mardis, PhD; Timothy J. Ley, MD; Richard K. Wilson, PhD